204 related articles for article (PubMed ID: 30081964)
21. A breed-matched case-control study of potential risk-factors for canine pyometra.
Hagman R; Lagerstedt AS; Hedhammar Å; Egenvall A
Theriogenology; 2011 Apr; 75(7):1251-7. PubMed ID: 21196041
[TBL] [Abstract][Full Text] [Related]
22. Immunophenotypic characterization of canine malignant lymphoma: a retrospective study of cases diagnosed in Poland Lower Silesia, over the period 2011-2013.
Pawlak A; Rapak A; Drynda A; Poradowski D; Zbyryt I; Dzimira S; Suchański J; Obmińska-Mrukowicz B
Vet Comp Oncol; 2016 Aug; 14 Suppl 1():52-60. PubMed ID: 25052381
[TBL] [Abstract][Full Text] [Related]
23. Canine atopic dermatitis: breed risk in Australia and evidence for a susceptible clade.
Mazrier H; Vogelnest LJ; Thomson PC; Taylor RM; Williamson P
Vet Dermatol; 2016 Jun; 27(3):167-e42. PubMed ID: 27188769
[TBL] [Abstract][Full Text] [Related]
24. Identification of common predisposing loci to hematopoietic cancers in four dog breeds.
Hédan B; Cadieu É; Rimbault M; Vaysse A; Dufaure de Citres C; Devauchelle P; Botherel N; Abadie J; Quignon P; Derrien T; André C
PLoS Genet; 2021 Apr; 17(4):e1009395. PubMed ID: 33793571
[TBL] [Abstract][Full Text] [Related]
25. Canine lymphoma: relative risk in the boxer breed.
Priester WA
J Natl Cancer Inst; 1967 Nov; 39(5):833-45. PubMed ID: 6066442
[No Abstract] [Full Text] [Related]
26. Breed predispositions in canine mast cell tumour: a single centre experience in the United Kingdom.
Warland J; Dobson J
Vet J; 2013 Aug; 197(2):496-8. PubMed ID: 23583004
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.
Ponce F; Magnol JP; Ledieu D; Marchal T; Turinelli V; Chalvet-Monfray K; Fournel-Fleury C
Vet J; 2004 Mar; 167(2):158-66. PubMed ID: 14975390
[TBL] [Abstract][Full Text] [Related]
28. Association between canine malignant lymphoma, living in industrial areas, and use of chemicals by dog owners.
Gavazza A; Presciuttini S; Barale R; Lubas G; Gugliucci B
J Vet Intern Med; 2001; 15(3):190-5. PubMed ID: 11380026
[TBL] [Abstract][Full Text] [Related]
29. Canine small clear cell/T-zone lymphoma: clinical presentation and outcome in a retrospective case series.
Martini V; Marconato L; Poggi A; Riondato F; Aresu L; Cozzi M; Comazzi S
Vet Comp Oncol; 2016 Aug; 14 Suppl 1():117-26. PubMed ID: 26040658
[TBL] [Abstract][Full Text] [Related]
30. Association of breed and histopathological grade in canine mast cell tumours.
Mochizuki H; Motsinger-Reif A; Bettini C; Moroff S; Breen M
Vet Comp Oncol; 2017 Sep; 15(3):829-839. PubMed ID: 27198171
[TBL] [Abstract][Full Text] [Related]
31. Increased prevalence of Borrelia burgdorferi infections in Bernese Mountain Dogs: a possible breed predisposition.
Gerber B; Eichenberger S; Wittenbrink MM; Reusch CE
BMC Vet Res; 2007 Jul; 3():15. PubMed ID: 17626630
[TBL] [Abstract][Full Text] [Related]
32. Cytopathology of canine lymphomas (100 cases).
Sapierzyński R; Micuń J; Jagielski D; Jurka P
Pol J Vet Sci; 2010; 13(4):653-9. PubMed ID: 21370743
[TBL] [Abstract][Full Text] [Related]
33. Retrospective study of canine cutaneous tumors in Japan, 2008-2017.
Kok MK; Chambers JK; Tsuboi M; Nishimura R; Tsujimoto H; Uchida K; Nakayama H
J Vet Med Sci; 2019 Aug; 81(8):1133-1143. PubMed ID: 31257236
[TBL] [Abstract][Full Text] [Related]
34. A retrospective study of the incidence and prognostic factors of multicentric lymphoma in dogs (1998-2000).
Jagielski D; Lechowski R; Hoffmann-Jagielska M; Winiarczyk S
J Vet Med A Physiol Pathol Clin Med; 2002 Oct; 49(8):419-24. PubMed ID: 12450190
[TBL] [Abstract][Full Text] [Related]
35. Canine Nervous System Lymphoma Subtypes Display Characteristic Neuroanatomical Patterns.
Sisó S; Marco-Salazar P; Moore PF; Sturges BK; Vernau W; Wisner ER; Bollen AW; Dickinson PJ; Higgins RJ
Vet Pathol; 2017 Jan; 54(1):53-60. PubMed ID: 27511313
[TBL] [Abstract][Full Text] [Related]
36. Swiss Canine Cancer Registry 1955-2008: Occurrence of the Most Common Tumour Diagnoses and Influence of Age, Breed, Body Size, Sex and Neutering Status on Tumour Development.
Grüntzig K; Graf R; Boo G; Guscetti F; Hässig M; Axhausen KW; Fabrikant S; Welle M; Meier D; Folkers G; Pospischil A
J Comp Pathol; 2016; 155(2-3):156-170. PubMed ID: 27406312
[TBL] [Abstract][Full Text] [Related]
37. Prior joint disease is associated with increased risk of periarticular histiocytic sarcoma in dogs.
Manor EK; Craig LE; Sun X; Cannon CM
Vet Comp Oncol; 2018 Mar; 16(1):E83-E88. PubMed ID: 28836371
[TBL] [Abstract][Full Text] [Related]
38. Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphoma.
Poggi A; Miniscalco B; Morello E; Comazzi S; Gelain ME; Aresu L; Riondato F
Vet Comp Oncol; 2015 Dec; 13(4):475-80. PubMed ID: 24341365
[TBL] [Abstract][Full Text] [Related]
39. Breed susceptibility for common surgically treated orthopaedic diseases in 12 dog breeds.
Boge GS; Moldal ER; Dimopoulou M; Skjerve E; Bergström A
Acta Vet Scand; 2019 Apr; 61(1):19. PubMed ID: 31023333
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous Tumors in Swiss Dogs: Retrospective Data From the Swiss Canine Cancer Registry, 2008-2013.
Graf R; Pospischil A; Guscetti F; Meier D; Welle M; Dettwiler M
Vet Pathol; 2018 Nov; 55(6):809-820. PubMed ID: 30131007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
